Business Standard

iNCOVACC: All you need to know about world's first intranasal Covid vaccine

The vaccine been approved for use as a primary as well as a heterologous (mix-and-match) booster dose in India

Bharat Biotech’s iNCOVACC, Bharat Bio’s nasal Covid vaccine, nasal Covid vaccine, Covid vaccine
Premium

iNCOVACC (BBV154) is India's first intranasal Covid-19 vaccine, and can be used for easy and painless immunisation against coronavirus.

BS Web Team New Delhi
India launched its first intranasal Covid-19 vaccine named iNCOVACC, on Thursday, January 26. Manufactured by Hyderabad-based Bharat Biotech, the intranasal vaccine was launched by Union Health Minister Mansukh Mandaviya and Union Minister of Science & Technology Jitendra Singh on India's 74th Republic Day.

The vaccine has been approved for use as a primary as well as a heterologous (mix-and-match) booster dose in India.

Here's everything you need to know about India's first intranasal vaccine for coronavirus:

What is iNCOVACC?

iNCOVACC (BBV154) is India's first intranasal Covid-19 vaccine, and can be used for easy and painless immunisation against coronavirus. According to

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 27 2023 | 5:17 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com